Congress Moves to Impose New Restrictions on Chinese Investments in Defense Bill
The U.S. Congress is advancing a defense authorization bill that introduces new restrictions on Chinese investments in sensitive sectors, aiming to reduce U.S. reliance on Chinese biotechnology companies. The bill, which has been approved by the House and is now headed to the Senate, includes provisions to scrutinize American investments in China that could enhance Chinese military capabilities. It also prohibits the use of government funds for equipment and services from blacklisted Chinese biotechnology companies. Additionally, the bill seeks to bolster U.S. support for Taiwan, which China claims as its own. The Chinese embassy in Washington has criticized the bill, accusing it of undermining bilateral relations and China's sovereignty. 
